Molecular Health to Present at Personalized Medicine World Conference

The company will present on personalized pharmacovigilance in oncology

HEIDELBERG, Germany & THE WOODLANDS, Texas--()--Molecular Health announced today that its chief innovation officer, David Jackson, Ph.D., will speak at this year’s Personalized Medicine World Conference, Silicon Valley. Dr. Jackson’s presentation, titled, “From Knowledge Innovation to Personalized Pharmacovigilance,” will highlight how the integrated computational analysis of genetic, pharmacological and clinical parameters can be used to identify safer effective treatment options for cancer patients.

As part of the “Detection and Molecular Analysis of Drug-induced Adverse Events” track, Dr. Jackson is scheduled to present on January 27th at 8:30 a.m. Pacific Time as part of Track 2 of the conference.

Also presenting as part of the “Detection and Molecular Analysis of Drug-induced Adverse Events” track is Molecular Health advisor and clinical professor and director of the Center for Pharmacometrics and Systems Pharmacology at the University of Florida in Orlando, Lawrence J. Lesko, Ph.D., F.C.P. Dr. Lesko’s presentation, titled, “Optimized Drug Treatments in Patient Care: Safety Matters,” will highlight how the industry needs to use existing targeted therapy drugs in the best way possible by understanding mechanisms related to drug safety, mitigating the risk of toxicities and thereby preserving the benefits of targeted therapies and the quality of life for patients.

Dr. Lesko is scheduled to present on January 27th at 8:15 a.m. Pacific Time as part of Track 2 of the conference.

The focus on and importance of understanding drug-induced adverse events in cancer has been a consistent part of Molecular Health’s technology-driven products, changing the way diseases are analyzed, understood and treated. From personalized risk analysis to personalized therapies, every product serves a special demand in the precision medicine continuum.

The Personalized Medicine World Conference is an independent conference that brings together experts across healthcare and biotechnology sectors to help further the adoption of personalized medicine in the clinic. This year’s Silicon Valley conference will be held on January 26th through the 28st at the Computer History Museum in Mountain View, California.

ABOUT MOLECULAR HEALTH

Molecular Health is an innovation-driven bioinformatics company headquartered in Heidelberg, Germany with offices in the United States. We are revolutionizing cancer treatment using a combination of individual patients’ molecular data and all relevant biomedical knowledge.

Please visit www.molecularhealth.com for more information and follow on Twitter at www.twitter.com/molecularhealth.

Website: www.molecularhealth.com
Twitter: www.twitter.com/molecularhealth
LinkedIn: www.linkedin.com/company/molecularhealth
YouTube: www.youtube.com/user/MolecularHealthInc

Contacts

Molecular Health
Contact for U.S.
Gregory FCA
Jessica Attanasio
Vice President
610-228-2112
Jessica@GregoryFCA.com
or
Contact for EU:
+49 62 21 43 85 11 85
media@molecularhealth.com

Release Summary

Molecular Health to Present at Personalized Medicine World Conference

Contacts

Molecular Health
Contact for U.S.
Gregory FCA
Jessica Attanasio
Vice President
610-228-2112
Jessica@GregoryFCA.com
or
Contact for EU:
+49 62 21 43 85 11 85
media@molecularhealth.com